NEWS - MARCH 2014
Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
PR Newswire March 12th, 2014
MADISON, N.J., March 12, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated(NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer $600,000,000 in aggregate principal amount of two series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions.
The issuance of the notes will be subject to customary closing conditions. The company intends to use the net proceeds from the offering to repay outstanding indebtedness under its senior unsecured revolving credit facility and secured receivables credit facility. Goldman, Sachs & Co., RBS Securities Inc., Wells Fargo Securities, LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC will be joint book-running managers for the debt offering. When available, copies of the preliminary prospectus supplement and the accompanying base prospectus for the offering can be obtained from Goldman, Sachs & Co. toll-free at (866) 471-2526, RBS Securities Inc. toll-free at (866) 884-2071, Wells Fargo Securities, LLC toll-free at (800) 326-5897, J.P. Morgan Securities LLC collect at (212) 834-4533 and Morgan Stanley & Co. LLC toll-free at (866) 718-1649.
This press release shall not constitute an offer to sell or a solicitation of an offer to purchase any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This offering may be made only by means of a prospectus supplement and accompanying base prospectus.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com. Follow us atFacebook.com/QuestDiagnostics and Twitter.com/QuestDX.
The statements in this press release which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management's current estimates, projections, expectations or beliefs and which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include, but are not limited to, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in "Business," "Risk Factors," "Cautionary Factors that May Affect Future Results," "Legal Proceedings," "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Quantitative and Qualitative Disclosures About Market Risk" in the company's 2013 Annual Report on Form 10-K and the company's 2014 Current Reports on Form 8-K.
Quest Diagnostics Contacts:
Wendy Bost (Media): 973-520-2800
Dan Haemmerle (Investors): 973-520-2900
Boomer & Carton: He Loves It When You Call Him Bob Papa
CBS New York March 14th, 2014
Bob Papa is a broadcaster in every sense of the word. From football to golf, Mr. Papa has got it all covered.
Well, following today’s show Papa and Boomer will be ‘taking a stand against colon cancer‘ so he stopped by the Allstate Studio to chat with Boomer & Craig about colon cancer awareness, the Giants and whatever else happened to come up…
Ex-Buffalo Bills QB Jim Kelly has Cancer Resurgance, Will Begin Treatment
Mike Rodak March 15th, 2014
Former Buffalo Bills quarterback Jim Kelly has been diagnosed with a recurrence of cancer.
Kelly had an initial surgery Wednesday to relieve pain on the left side of his face and jaw area. He will have another surgery a week from Tuesday and then is expected to undergo five to six weeks of radiation and chemotherapy.
"I need lots of prayers," Kelly said.
Erie County Medical Center, the Buffalo, N.Y., hospital treating Kelly, released a statement saying, "Jim Kelly came to ECMC this week for continued testing related to his oral surgery. Unfortunately, it has been determined that his cancer has returned. Our team of head and neck cancer specialists is determining a course of treatment that will allow Mr. Kelly to battle this cancer successfully. Mr. Kelly has asked that you keep him and his family in your thoughts and prayers."
Kelly underwent surgery last June to remove cancerous cells in his jaw. At the time, chemotherapy and radiation treatment were not necessary.
Kelly, who played for the Bills from 1986 to 1996, was inducted into the Pro Football Hall of Fame in 2002. He holds nearly all of the franchise's passing records.
His son, Hunter, was born with Krabbe disease, an inherited nervous system disorder. Given little more than three years to live, Hunter died at the age of 8 in 2005.
The Associated Press contributed to this report.